|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10538 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-Peroxin 5R/PEX5-related protein |
| 克隆性 | |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Peroxin 5R/PEX5-related protein |
產(chǎn)品訂購(gòu)信息：
英文名稱(chēng) Anti-Peroxin 5R/PEX5-related protein
中文名稱(chēng) 過(guò)氧化物酶體生成蛋白5相關(guān)蛋白抗體規(guī)格
別 名 Peroxin 5 related protein; Peroxisome biogenesis factor 5 like; PEX2 related protein; PEX5-like protein; PEX5R; Pex5Rp; PXR2B; PEX5R_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 神經(jīng)生物學(xué) 通道蛋白 細(xì)胞膜受體
蛋白分子量 predicted molecular weight: 70kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Peroxin 5R/PEX5-related protein
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
過(guò)氧化物酶體生成蛋白5相關(guān)蛋白抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Peroxisomes are single-membrane bound organelles present in virtually all eukaryotic cells. They are involved in numerous catabolic and anabolic pathways, including beta-oxidation of very long chain fatty acids, metabolism of hydrogen peroxide, plasmalogen biosynthesis and bile acid synthesis. The Peroxin gene family, which includes more than 20 members, is required for peroxisome biogenesis. Peroxin 5R, also known as PEX5-related protein or Peroxisome biogenesis factor 5-like, is a 626 amino acid protein that is mainly expressed in brain, with some expression in testis and pancreas. Peroxin 5R contains five TPR repeats, which enable protein-protein interactions and assembly of large multiprotein complexes. There are three isoforms of Peroxin 5R that are produced as a result of alternative splicing events. These isoforms bind C-terminal peroxisome-targeting signals in a similar manner to Peroxin-5. Peroxin 5R interacts with Rab 8b, possibly playing a role in vesicular trafficking and neurotransmitter release.
Function : Belongs to the peroxisomal targeting signal receptor family. Contains 5 TPR repeats.
Subunit : Interacts with RAB8B (By similarity). May interact with the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type); the relevance of such interaction is however unclear.
Subcellular Location : Cytoplasm. Membrane; Peripheral membrane protein.
Similarity : Belongs to the peroxisomal targeting signal receptor family.
Contains 5 TPR repeats.
Database links : UniProtKB/Swiss-Prot: Q8IYB4.2
Anti-Gab1/FITC 熒光素標(biāo)記兔抗人、大、小鼠接頭蛋白Gab 1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Nitric oxide/NO/FITC 熒光素標(biāo)記抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh BRN3A 轉(zhuǎn)錄因子Brn3蛋白抗體Brn3α 規(guī)格 0.1ml
phospho-AR/androgen receptor( p-Ser580)peptide 雄激素受體(多肽) 0.5mg
HOXA9 英文名稱(chēng)： 同源盒蛋白HOXA9抗體 0.1ml
Rhesus antibody Rh rHPV 重組人瘤病毒抗體 規(guī)格 0.2ml
Anti-Nitric oxide/NO/FITC 熒光素標(biāo)記抗體IgGMulti-class antibodies規(guī)格： 0.2ml
ATM(Human Ataxia telangiectasia mutated) ELISA Kit 人性突變基因Multi-class antibodies規(guī)格： 48T
Anti-PIBF 孕激素誘導(dǎo)阻斷因子抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh HIST1H2AH 組蛋白H2A/S抗體 規(guī)格 0.2ml
THAA(Human thyroid hormone autoantibodies) ELISA Kit 人甲狀腺非肽激素抗體 96T
PLTP 英文名稱(chēng)： 磷脂轉(zhuǎn)移蛋白抗體 0.1ml
CHRDL2 英文名稱(chēng)： 新因子1抗體 0.1ml
Anti-PIBF 孕激素誘導(dǎo)阻斷因子抗體Multi-class antibodies規(guī)格： 0.2ml
AST(Human Aspartate aminotransferase) ELISA Kit 人天門(mén)冬氨酸氨基轉(zhuǎn)移酶Multi-class antibodies規(guī)格： 48T
Anti-NGAL/Lipocalin 2 脂質(zhì)運(yùn)載蛋白抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh IL-17R/IL-17RA/CD217 白介素17受體抗體 規(guī)格 0.1ml
IL-3 ELISA Kit 大鼠白介素3 96T
phospho-PRKD1(Ser742) 英文名稱(chēng)： 磷酸化蛋白激酶C mu型抗體 0.1ml
Raf1 英文名稱(chēng)： 癌基因c-Raf抗體 0.1ml
Anti-NGAL/Lipocalin 2 脂質(zhì)運(yùn)載蛋白抗體Multi-class antibodies規(guī)格： 0.2ml
CL-0436SF17(人細(xì)胞)5×106cells/瓶×2
CCNA1 Others Human 人 CCNA1 / Cyclin-A1 桿狀病毒-昆蟲(chóng)細(xì)胞裂解液 (陽(yáng)性對(duì)照)
人肺動(dòng)脈內(nèi)皮細(xì)胞RNAHPAEC miRNA5 μg
H08910細(xì)胞，細(xì)胞 人細(xì)胞,H125細(xì)胞 MLF, 小鼠淋巴成纖維細(xì)胞
豚鼠皮膚細(xì)胞;GP-S1
TNFRSF17 Others Mouse 小鼠 TNFRSF17 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CL-0435SF126(人細(xì)胞)5×106cells/瓶×2
HA Others H12N1 甲型 H12N1 (A/mallard duck/Alberta/342/1983) 血凝素 (Hemagglutinin / HA) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
大鼠視網(wǎng)膜神經(jīng)節(jié)細(xì)胞完全培養(yǎng)基 100mL
HL-7702人正常肝細(xì)胞 HL-7702 human normal liver cell 1640+10% FBS
IL1RN Protein Rat 重組大鼠 IL-1RA / IL1RN 蛋白 (Fc 標(biāo)簽)
NCI-H596(人肺腺鱗癌細(xì)胞) 5×106cells/瓶×2 cv-1(非洲綠猴腎細(xì)胞)
過(guò)氧化物酶體生成蛋白5相關(guān)蛋白抗體規(guī)格 TSPAN31 Others Human 人 TSPAN31 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CM-H045人肝動(dòng)脈平滑肌細(xì)胞完全培養(yǎng)基100mL
人少突膠質(zhì)前體細(xì)胞-貼壁生長(zhǎng)HOPC
CCC-ESF-1細(xì)胞，人胚胎皮膚成纖維細(xì)胞 人癌細(xì)胞,MDA-MB-415細(xì)胞 口腔角質(zhì)細(xì)胞培養(yǎng)基OKM
瘤牛皮膚細(xì)胞;BIN-S1
KLK1 Others Human 人 KLK-1 / Kallikrein-1 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 過(guò)氧化物酶體生成蛋白5相關(guān)蛋白抗體規(guī)格 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴(lài)氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定：
1）過(guò)氧化物酶體生成蛋白5相關(guān)蛋白抗體規(guī)格 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線(xiàn),計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
|
|
|
|
